InSpek is a biotools company redefining bioprocess manufacturing through real-time monitoring and artificial intelligence. Its bioprocess optimization platform doesn’t just analyse data — it collects it, thanks to proprietary photonic sensing technology developed at MIT and CNRS. On-chip optical sensors capture rich, multimodal process data at any scale, directly within bioreactors, without sampling and without contamination risk. This fuels AI and chemometric models that learn process dynamics, detect anomalies, and identify optimal operating conditions — enabling higher yields, lower costs, and faster scale-up.

At the core of InSpek’s platform is MultiSpek: a single disposable microchip integrating Raman spectroscopy, pH, dissolved oxygen, temperature, and optical density sensing onto one photonic integrated circuit. Paired with a reusable control unit and intelligent software, the system delivers continuous, label-free, in-line analysis of critical process parameters — from metabolite concentrations to cell density — replacing slow, costly offline methods like HPLC. Designed for seamless integration into both single-use and stainless-steel bioreactors, MultiSpek supports upstream and downstream process intensification from early R&D through full-scale production.

This shift from batch-based sampling to fully continuous monitoring empowers pharmaceutical, biotech, and food-tech manufacturers to optimize yields, ensure consistent product quality, and accelerate process development — while reducing costs, resource consumption, and environmental impact. InSpek’s technology drives the transition toward smart, data-centric biomanufacturing in compliance with PAT frameworks, and Biomanufacturing 4.0.